The Medical House PLC

The Medical House PLC (TMH) is engaged in the development and supply of innovative delivery systems for injectable drugs. Its products include ASI, a single-use, disposable autoinjector; and Needle-free Jet Injectors, which utilize spring power to inject liquid drugs without a needle. In addition, the company offers contract development services including creation of new device technologies and improvement of customers existing technologies. The company has partnerships with Catalent Pharma Solutions, Stallergenes, Dr Reddy`s Laboratories, European Government Agency and Merck Serono, to provide its licensing technologies and cost effective devices. The company is ISO 9001 and ISO 13485 certified, and compliant with FDA CFR 21 820 and MDD 93/42 EEC. It focuses on research and development (R&D) activities to develop and introduce innovative technologies in the market. TMH is headquartered in England, the UK.The company reported revenues of (British Pounds) GBP 2.93 million during the fiscal year ended December 2008, an increase of 72.43% over 2007. The operating profit of the company was GBP 0.72 million during the fiscal year 2008, whereas the company reported an operating loss of GBP 0.05 million during 2007. The net profit of the company was GBP 0.06 million during the fiscal year 2008, whereas the company reported a net loss of GBP 0.94 million during 2007.